May F. Elbanna (@mayelbannamdphd) 's Twitter Profile
May F. Elbanna

@mayelbannamdphd

Radiation Oncologist @MayoRadOnc via @IUradonc,#IMG🇪🇬, PhD @iumedschool, MSc @ucl, @fulbrightprgrm scholar #globaloncology,#PROs,#percisionmedicine

ID: 1128880776706236416

linkhttps://scholar.google.com/citations?hl=en&user=Ppm6IlYAAAAJ calendar_today16-05-2019 04:32:05

1,1K Tweet

1,1K Takipçi

1,1K Takip Edilen

United Nations (@un) 's Twitter Profile Photo

In this Holy Month, let us all embrace our common humanity to build a more just and peaceful world for all. — António Guterres as millions of people around the world begin to observe #Ramadan.

In this Holy Month, let us all embrace our common humanity to build a more just and peaceful world for all.

— <a href="/antonioguterres/">António Guterres</a> as millions of people around the world begin to observe #Ramadan.
Bradley Stish (@drstish) 's Twitter Profile Photo

We have a great opportunity for a Radiation Oncologist to join our team in Eau Claire. jobs.mayoclinic.org/job/eau-claire… Please reach out to me directly if you have any questions.

Nadia Laack, MD MS (@n_laack) 's Twitter Profile Photo

Thanks to Emily and team at ASTRO for hosting another great chairs meeting. And thanks to all the chairs who made time to support each other on this leadership journey

Thanks to Emily and team at  <a href="/ASTRO_org/">ASTRO</a> for hosting another great chairs meeting. And thanks to all the chairs who made time to support each other on this leadership journey
Adela (@adelapoite) 's Twitter Profile Photo

Revisiting Margin Width Guidelines for DCIS and the Role of Routine Reexcision - The ASCO Post ascopost.com/news/may-2025/…

Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

MY TOP 10 picks for #ASCO25: ASCO The ASCO Post Plenary sessions: · LBA1: Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).

Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

📢This might just be THE DEFINITIVE meta-analysis of PSMA PET for #prostatecancer recurrence. 🚨Meta-analysis of 43 studies (n=8,119) ⬆️Sensitivity from 48% at PSA 0.2–0.5 ng/ml to >90% at PSA >2. Congrats Declan Murphy marlon perera + team European Association of Urology (EAU)! ➡️link shorturl.at/unfn5

📢This might just be THE DEFINITIVE meta-analysis of PSMA PET for #prostatecancer recurrence. 
🚨Meta-analysis of 43 studies (n=8,119)
⬆️Sensitivity from 48% at PSA 0.2–0.5 ng/ml to &gt;90% at PSA &gt;2. Congrats <a href="/declangmurphy/">Declan Murphy</a> <a href="/drMPerera/">marlon perera</a> + team <a href="/Uroweb/">European Association of Urology (EAU)</a>! 
➡️link shorturl.at/unfn5
Gerry Hanna (@gerryhanna) 's Twitter Profile Photo

Results from FAST-Forward Nodal substudy published in Radiotherapy & Oncology ➡️26 Gy/5Fr non-inferior to 40 Gy/15Fr for hand swelling at 5 years ➡️No cases of radiation-induced brachial plexopathy ➡️Other patient-reported outcomes were similar 🔗doi.org/10.1016/j.rado…

Results from FAST-Forward Nodal substudy published in <a href="/RO_GreenJournal/">Radiotherapy & Oncology</a> 

➡️26 Gy/5Fr non-inferior to 40 Gy/15Fr for hand swelling at 5 years
➡️No cases of radiation-induced brachial plexopathy 
➡️Other patient-reported outcomes were similar 

🔗doi.org/10.1016/j.rado…
Daniel Ma (@danielmamd) 's Twitter Profile Photo

The MN delegation for ASTRO Advocacy Day joined with diverse rad oncs from multiple states to champion NIH/NCI funding, prior auth reform, and support for ROCR. Hopeful and optimistic that we can preserve cancer research and #radonc for future generations. #ASTROAdvocacy

The MN delegation for <a href="/ASTRO_org/">ASTRO</a> Advocacy Day joined with diverse rad oncs from multiple states to champion NIH/NCI funding, prior auth reform, and support for ROCR. Hopeful and optimistic that we can preserve cancer research and #radonc for future generations. #ASTROAdvocacy
Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

Come on #ASCO25, this 💯 should have been a plenary! 7% improvement in 8-yr OS w exercise in adjuvant colon ca, greater than benefit for adding oxali to 5-FU (5% at 10 yrs in MOSAIC). Exercise = $ effective, ~0 tox, & gives pts sense of empowerment. Congrats Chris Booth et al!

Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

👏🏽👏🏽👏🏽🎉 Such a cool trial! Really proud of Peter Mac Radiation Oncology led trial by Steven David - really clinically pragmatic design in oligoprogressive #breastcancer #radonc

May F. Elbanna (@mayelbannamdphd) 's Twitter Profile Photo

Congratulations for the Egyptian Cancer Society for signing an agreement with ⁦ASCO⁩ to advance Cancer Research in Egypt 🇪🇬 and the MENA region 👏 #ASCO2025 ⁦Dr. Nagla Abdel Karim⁩ ⁦⁦Lamiaa Abdallah

Congratulations for the Egyptian Cancer Society for signing an agreement with ⁦<a href="/ASCO/">ASCO</a>⁩ to advance Cancer Research in Egypt 🇪🇬 and the MENA region 👏 #ASCO2025 ⁦<a href="/NaglaAKarimMD/">Dr. Nagla Abdel Karim</a>⁩ ⁦⁦<a href="/LamiaaMd/">Lamiaa Abdallah</a>⁩
Myrsini Ioakeim-Ioannidou, MD (@myrsiniioakeim) 's Twitter Profile Photo

Practice-changing data from Dr. Steven Frank Steven J. Frank, MD at #PTCOG63 on head & neck proton therapy. Level 1 evidence shows improved survival, reduced G-tube dependence, and favorable cost-effectiveness vs IMRT. A new standard is taking shape. The Particle Therapy Co-Operative Group (PTCOG) MD Anderson Cancer Center

Practice-changing data from Dr. Steven Frank <a href="/SJFrankMD/">Steven J. Frank, MD</a> at #PTCOG63 on head &amp; neck proton therapy. Level 1 evidence shows improved survival, reduced G-tube dependence, and favorable cost-effectiveness vs IMRT. A new standard is taking shape. <a href="/PTCOG_Official/">The Particle Therapy Co-Operative Group (PTCOG)</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

Mayo Clinic - wow what teamwork! This place just oozes good culture! For a busy clinical facing-practice; so impressed with working environment. No wonder the staff love working here! Thanks for having me as visiting prof 🙏🏽🙏🏽

<a href="/MayoClinic/">Mayo Clinic</a> - wow what teamwork! This place just oozes good culture! For a busy clinical facing-practice; so impressed with working environment. No wonder the staff love working here! Thanks for having me as visiting prof 🙏🏽🙏🏽
NEJM (@nejm) 's Twitter Profile Photo

In women with node-positive breast cancer whose nodes became free of disease after neoadjuvant therapy, regional nodal irradiation did not reduce breast cancer recurrence or improve survival. Full results from a phase 3 trial: nej.md/4dM6LjD

In women with node-positive breast cancer whose nodes became free of disease after neoadjuvant therapy, regional nodal irradiation did not reduce breast cancer recurrence or improve survival. Full results from a phase 3 trial: nej.md/4dM6LjD
Tyler Seibert MD PhD (@tylersbrt) 's Twitter Profile Photo

🚨🚨10-year results of FLAME 🔥 out in Journal of Clinical Oncology ⬇️ bDFS (15%), local recurrence ⬇️ nodal metastasis No diff in toxicity—this is a freebie! DMFS 87% vs 83% (p=0.12) — more in 🧵 👇🏼 OncoAlert PCF Science Prostate Cancer UK ASTRO OncoDaily UroToday.com ascopubs.org/doi/pdf/10.120…

JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Viewpoint: The rise in early-onset cancers in individuals under 50 may be explained by accelerated biological aging, with aging and cancer sharing common mechanisms. ja.ma/4myVLcs

Viewpoint: The rise in early-onset cancers in individuals under 50 may be explained by accelerated biological aging, with aging and cancer sharing common mechanisms. 

ja.ma/4myVLcs
Laura Vater, MD, MPH (@doclauravater) 's Twitter Profile Photo

Thank you to every mentor who ever wrote me a letter of recommendation. Now (on the other side of this writing letters for med students & residents), I know how much time, effort, and detailed attention this takes, on top of all the other clinical and admin tasks. Thank you.